- Login
- Register & Subscribe
- Language: EN FR DE
Friday 2 July 2010
Benoît Battistelli
Benoît Battistelli became president of the European Patent Office on 1 July 2010, succeeding Alison Brimelow who held the job since July 2007.
Country: France
Thursday 24 June 2010
Athos Gianella-Borradori
Clavis Pharma ASA has appointed Athos Gianella-Borradori, an onco-haematologist and drug developer, as its new chief medical officer.
Country: Norway
Wednesday 9 June 2010
Laurent Audoly
Pieris AG, which is developing a platform based of high penetration lipocalins called Anticalins, has appointed Laurent Audoly as chief scientific officer.
Country: Germany
Wednesday 9 June 2010
Melya Hughes Crameri
Evolva Holding SA, an early stage, genetic chemistry company, said that the chief executive of its US subsidiary, Genetic Chemistry Inc of California, has resigned and will be replaced temporarily
Country: Switzerland
Wednesday 2 June 2010
Aram Mangasarian
Noxxon Pharma AG has appointed Aram Mangasarian as chief business officer, with responsibility for the corporate and business development activities of the company.
Country: Germany
Wednesday 2 June 2010
Anders Wiklund
Clavis Pharma A/S, which is developing lipid technology for delivering anti-cancer drugs, has appointed two new board members to replace three resigning members.
Country: Norway
Wednesday 2 June 2010
Martin Welschof
Following the takeover of Affitech A/S by two Russian biotech entrepreneurs in April, the chief executive, Robert Burns has resigned.
Country: Norway
Wednesday 2 June 2010
Erwan Martin
Genomic Vision SA, a French molecular instrumentation and diagnostics company, has appointed Erwan Martin as chief financial officer and Emmanuel Conseiller as vice president for research and devel
Country: France
Wednesday 2 June 2010
Emmanuel le Poul
Addex Pharmaceuticals said its CNS business director, Emmanuel le Poul, has left the company to pursue other opportunities and will not be replaced in the short term.
Country: Switzerland
Saturday 29 May 2010
Martin Mackay
AstraZeneca Plc has appointed Martin Mackay, formerly head of pharma therapeutics research and development at Pfizer Inc, to the newly created post of president of research and development, ef
Country: United Kingdom
Tuesday September 7 2010
Friday September 3 2010
Friday August 20 2010
Friday August 20 2010
Thursday August 19 2010